RedHill Biopharma Ltd. (RDHL) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

RedHill Biopharma Ltd. (RDHL) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $2.1M, listed on NASDAQ, employing roughly 13 people, carrying a beta of 4.90 to the broader market. RedHill Biopharma Ltd. Led by Dror Ben-Asher, public since 2013-01-07.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for RDHL as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →